|
| Status |
Public on Mar 08, 2013 |
| Title |
786-O_SAHA_NoE |
| Sample type |
genomic |
| |
|
| Source name |
786-O Cell Line
|
| Organism |
Homo sapiens |
| Characteristics |
Sex: male
treatment: SAHA treated
cell line: 786-O Cell Line
|
| Treatment protocol |
2x10^5 nuclei were treated with 1x M.SssI buffer and 50U of M.SssI for 15 minutes. A no-enzyme control was included. SAHA treatment was performed for 24hours with 1uM SAHA
|
| Growth protocol |
Cells were grown under standard conditions
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
Genomic DNA was extracted using standard phenol chloform procedures with ethanol precipitation. Zymo EZ DNA kit was used for bisulfite conversion
|
| Label |
Cy5 and Cy3
|
| Label protocol |
Standard Illumina labeling protocol
|
| |
|
| Hybridization protocol |
Bisulfite converted DNA was amplified, fragmented and hybridized to the Illumina 450k methylation array using standard Illumina protocols
|
| Scan protocol |
Beadchips were imaged using Illumina BeadArray Reader using standard recommended Illumina scanner setting.
|
| Description |
male, renal cancer cell line, SAHA treated
|
| Data processing |
Mean non-background corrected signal intensities of the methylated (M) and unmethylated (U) for each CpG locus were extracted using the Illumina BeadStudio software v3.2.Data points were marked “NA” if 1) Probes contained single-nucleotide polymorphisms (SNPs), 2) those that overlap with a repetitive element that covers the targeted CpG dinucleotide, 3) those that overlap with regions of insertions and deletions in the human genome. Beta values with detection P value greater than 0.05 were also replaced as NA. Furthermore, probes containing at least one “NA” across the tumor sample set were masked as “NA”. Beta values were background subtracted.
|
| |
|
| Submission date |
Jan 29, 2013 |
| Last update date |
Mar 08, 2013 |
| Contact name |
Kurinji Pandiyan |
| Organization name |
University of Southern California
|
| Department |
Department of Urology - Norris Comprehensive Cancer Center
|
| Street address |
1441 Eastlake Avenue NOR 7344
|
| City |
Los Angeles |
| ZIP/Postal code |
90033 |
| Country |
USA |
| |
|
| Platform ID |
GPL13534 |
| Series (2) |
| GSE38858 |
AcceSssIble Assay to Study the Chomatin Accessibility and DNA Methylation |
| GSE43851 |
Functional DNA methylation is accompanied by chromatin accessibility [methylation] |
|
